Jefferies Group LLC Glaukos Corp Call Options Transaction History

Jefferies Group LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 Sep 21, 2023	BUY	$44.33 - $57.82 $4.9 Million - $6.39 Million	110,600 Added 737.33%	125,600 $7.26 Million
Q1 2022 May 16, 2022	BUY	$44.33 - $57.82 $4.9 Million - $6.39 Million	110,600 Added 737.33%	125,600 $7.26 Million
Q4 2021 Sep 21, 2023	BUY	$40.27 - $56.99 $604,050 - $854,850	15,000 New	15,000 $666,000
Q4 2021 Feb 14, 2022	BUY	$40.27 - $56.99 $604,050 - $854,850	15,000 New	15,000 $667,000
Q1 2019 May 15, 2019	SELL	$50.75 - $80.54 $1.28 Million - $2.04 Million	-25,300 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$52.18 - $67.93 $2.93 Million - $3.82 Million	-56,200 Reduced 68.96%	25,300 $1.42 Million
Q3 2018 Nov 14, 2018	BUY	$38.13 - $68.37 $1.15 Million - $2.06 Million	30,200 Added 58.87%	81,500 $5.29 Million
Q2 2018 Aug 14, 2018	BUY	$27.62 - $44.51 $1.42 Million - $2.28 Million	51,300 New	51,300 $2.09 Million

340

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.85B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.